...
首页> 外文期刊>Current Protocols in Mouse Biology >Optimized Heart Sampling and Systematic Evaluation of Cardiac Therapies in Mouse Models of Ischemic Injury: Assessment of Cardiac Remodeling and Semi-Automated Quantification of Myocardial Infarct Size
【24h】

Optimized Heart Sampling and Systematic Evaluation of Cardiac Therapies in Mouse Models of Ischemic Injury: Assessment of Cardiac Remodeling and Semi-Automated Quantification of Myocardial Infarct Size

机译:优化的心脏采样和缺血性损伤小鼠模型的心脏疗法的系统评价:心脏重塑和心肌梗死面积的半自动量化评估

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac therapies are commonly tested preclinically in small-animal models of myocardial infarction. Following functional evaluation, post-mortem histological analysis is essential to assess morphological and molecular alterations underlying the effectiveness of treatment. However, non-methodical and inadequate sampling of the left ventricle often leads to misinterpretations and variability, making direct study comparisons unreliable. Protocols are provided for representative sampling of the ischemicmouse heart followed by morphometric analysis of the left ventricle. Extending the use of this sampling to other types of in situ analysis is also illustrated through the assessment of neovascularization and cellular engraftment in a cell-based therapysetting. This is of interest to the general cardiovascular research community as it details methods for standardization and simplification of histo-morphometric evaluation of emergent heart therapies.
机译:心脏疗法通常在小动物心肌梗死模型中进行临床前测试。功能评估后,验尸组织学分析对于评估治疗有效性的形态学和分子变化至关重要。然而,左心室的非方法学和不充分的采样常常会导致错误的解释和可变性,使得直接的研究比较不可靠。提供了用于缺血性心脏心脏的代表性采样以及随后的左心室形态分析的方案。通过在基于细胞的治疗设置中评估新血管形成和细胞植入,还可以说明将此采样的使用扩展到其他类型的原位分析。通用心血管研究界对此很感兴趣,因为它详细介绍了用于标准化和简化新兴心脏疗法的组织形态计量学评估的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号